Why is Remus Pharma. falling/rising?

As of 10-Sep, Remus Pharmaceuticals Ltd is currently priced at 843.65, reflecting an increase of 15.75 or 1.9%. Despite this uptick, the stock has shown a negative performance over the past week, down 4.20%, and has also declined by 1.08% over the past month. Year-to-date, the stock has dropped significantly by 32.44%, and over the past year, it has decreased by 33.53%. The stock is currently trading 2.92% above its 52-week low of Rs 819. However, it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. On a positive note, there has been a rise in investor participation, with delivery volume increasing by 12.61% compared to the 5-day average, indicating some renewed interest in the stock.
In the broader market context, the Sensex has performed positively, gaining 1.04% over the past week and 2.50% over the past month, while Remus Pharmaceuticals has lagged behind these benchmarks. Year-to-date, the Sensex has increased by 5.62%, contrasting sharply with the substantial decline in Remus Pharmaceuticals' stock price. This divergence suggests that while the overall market is experiencing growth, Remus Pharmaceuticals is facing challenges that have led to its significant underperformance relative to the benchmark. The absence of specific positive or negative factors in the dashboard limits the ability to pinpoint exact reasons for the stock's recent movements, but the overall trend indicates a struggle against a backdrop of a rising market.